The much broader issues, which surfaced at the American College of Rheumatology meetings, were most disturbing and involve suppression of data by Merck and a consistent pattern of intimidation of investigators by Merck staff...Zyprexa documents, Vioxx documents, Neurontin documents, what's next? If there are any bored researchers, journalists, or bloggers out there, start reading!
Hat Tip: PharmaGossip.
No comments:
Post a Comment